Papillomavirus vaccines in clinical trials.
Explore this paper's citation graph
Summary
A firm grasp of the molecular pathogenesis of HPVs and the natural history of genital HPV infections, combined with greater understanding of how to trigger effective immune responses, offers hope for the elimination of HPV-associated diseases.
- Type
- review
- Published
- 2003-08-01
- Cited by
- 109
- References
- 91
- OpenAlex
- https://openalex.org/W2009714442
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:30108201
Keywords
Medicine, Cervical cancer, Clinical trial, HPV vaccines, HPV infection
References
- Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection
- Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins
- Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles
- Human papillomavirus and lower genital neoplasia in renal transplant patients
- Cervical Intraepithelial Neoplasia and Human Papillomavirus Infection among Senegalese Women Seropositive for HIV-1 or HIV-2 or Seronegative for HIV
- Strategies for studying mouse and human immune responses to human papillomavirus type 16.
- Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11
- Established Human Papillomavirus Type 16-Expressing Tumors Are Effectively Eradicated Following Vaccination with Long Peptides1
- Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.
- A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer.
- Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles
- Induction of Human Papillomavirus-Specific CD4+ and CD8+ Lymphocytes by E7-Pulsed Autologous Dendritic Cells in Patients with Human Papillomavirus Type 16- and 18-Positive Cervical Cancer
- Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.
- HPV6b virus like particles are potent immunogens without adjuvant in man.
- Infectious cycle of human papillomavirus type 11 in human foreskin xenografts in nude mice
- Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7.
- Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids
- Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA binding and capsid assembly
- Structure and transcription of human papillomavirus sequences in cervical carcinoma cells
- A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions.
Cited by
- Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.
- Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix.
- Human Papillomavirus, Cervical Cancer, and the Vaccines
- T cell immunity against early antigens of Human Papillomavirus type 16
- Large scale study of HPV genotypes in cervical cancer and different cytological cervical specimens in Thailand
- Update on the pathogenesis and immunotherapy of esophageal squamous cell carcinoma.
- Prevalence of human papillomavirus cervical infection in an Italian asymptomatic population
- Efecto citopático por el Virus del Papiloma Humano (HPV)
- Immunology of the genital tract - a review
- The allelic distribution of -308 Tumor Necrosis Factor-alpha gene polymorphism in South African women with cervical cancer and control women
- Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins
- The humoral immune responses after HPV infection and prophylactic vaccination: Importance of serology
- Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
- Re-adapting T cells for cancer therapy: from mouse models to clinical trials
- La infección por el virus del papiloma humano
- HPV and Cervical Cancer: Updates on an Established Relationship
- Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein–based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia
- Distribution of Six Oncogenic Types of Human Papillomavirus and Type 16 Integration Analysis in Chinese Women with Cervical Precancerous Lesions and Carcinomas
- Cáncer de cuello uterino: Estado actual de las vacunas frente al virus del papiloma humano (VPH)
- Human Papillomavirus (HPV) Detection Among Human Immunodeficiency Virus–Infected Pregnant Thai Women: Implications for Future HPV Immunization
Related papers
- TNF-Alpha rs1800629 Polymorphism Is Not Associated with HPV Infection or Cervical Cancer in the Chinese Population
- Genital human papillomavirus infections in the male sexual partners of 45 female patients with papillomavirus infection.
- Human papilloma virus type 16 infection and the early onset of cervical cancer.
- Regional Distribution of Different Types of Human Papillomavirus in Cervixes of Chinese Women: A Meta-analysis
- Epidemiology of genital human papillomavirus infection.
- Human semen: the biological basis of sexual behaviour to promote human papillomavirus infection and cervical cancer.
- Progress in Research on Cervical Cancer Vaccine
- [HPV infection as a disease of couples. Prevalence of the infection in the male partner].
- European approval for cervical cancer vaccine